Back to Iowa

HF2009 • 2026

A bill for an act relating to manufacturers and distributors of 340B drugs.

A bill for an act relating to manufacturers and distributors of 340B drugs.

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
BARKER
Last action
2026-01-21
Official status
Subcommittee recommends passage.
Effective date
Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

A bill for an act relating to manufacturers and distributors of 340B drugs.

A bill for an act relating to manufacturers and distributors of 340B drugs.

What This Bill Does

  • A bill for an act relating to manufacturers and distributors of 340B drugs.

Limits and Unknowns

  • This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

  1. 2026-01-21 Iowa Legislature

    Subcommittee recommends passage.

  2. 2026-01-21 Iowa Legislature

    Subcommittee Meeting: 01/21/2026 4:00PM House Lounge 2.

  3. 2026-01-14 Iowa Legislature

    Subcommittee: Barker, Bergan and Wilburn. H.J. 97 .

  4. 2026-01-13 Iowa Legislature

    Introduced, referred to Health and Human Services. H.J. 41 .

Official Summary Text

A bill for an act relating to manufacturers and distributors of 340B drugs.

Current Bill Text

Read the full stored bill text
House

File

2009

-

Introduced

HOUSE

FILE

2009

BY

BARKER

A

BILL

FOR

An

Act

relating

to

manufacturers

and

distributors

of

340B

1

drugs.

2

BE

IT

ENACTED

BY

THE

GENERAL

ASSEMBLY

OF

THE

STATE

OF

IOWA:

3

TLSB

5704YH

(1)

91

nls/ko

H.F.

2009

Section

1.

Section

510D.1,

Code

2026,

is

amended

by

adding

1

the

following

new

subsections:

2

NEW

SUBSECTION

.

01.

“340B

drug”

means

a

covered

outpatient

3

drug

for

which

a

manufacturer

has

offered

a

reduced

price

4

pursuant

to

42

U.S.C.

§256b,

and

that

is

purchased

by

a

covered

5

entity.

6

NEW

SUBSECTION

.

4A.

“Distributor”

means

a

person,

other

7

than

a

manufacturer,

engaged

in

the

wholesale

distribution

of

8

a

prescription

drug

to

a

retail

community

pharmacy,

including

9

but

not

limited

to

repackers,

jobbers,

brokers,

warehouses,

10

independent

wholesale

drug

traders,

and

retail

community

11

pharmacies

that

conduct

wholesale

distributions.

12

NEW

SUBSECTION

.

5A.

“Manufacturer”

means

the

same

as

13

defined

in

section

1927(k)(5)

of

the

federal

Social

Security

14

Act.

15

Sec.

2.

Section

510D.2,

Code

2026,

is

amended

by

adding

the

16

following

new

subsection:

17

NEW

SUBSECTION

.

4.

A

manufacturer

or

distributor

shall

not,

18

either

directly

or

indirectly,

deny,

restrict,

or

otherwise

19

interfere

with

the

acquisition

of

a

340B

drug

by

a

covered

20

entity,

or

delivery

of

a

340B

drug

to

a

contract

pharmacy,

21

unless

such

purchase

or

receipt

is

prohibited

by

the

United

22

States

department

of

health

and

human

services.

23

EXPLANATION

24

The

inclusion

of

this

explanation

does

not

constitute

agreement

with

25

the

explanation’s

substance

by

the

members

of

the

general

assembly.

26

This

bill

relates

to

manufacturers

and

distributors

of

340B

27

drugs.

28

“340B

drug”,

“manufacturer”,

and

“distributor”

are

defined

29

in

the

bill.

The

bill

prohibits

a

manufacturer

or

distributor

30

from,

directly

or

indirectly,

denying,

restricting,

or

31

interfering

with

the

acquisition

of

a

340B

drug

by

a

covered

32

entity,

or

the

delivery

of

a

340B

drug

to

a

contract

pharmacy,

33

unless

otherwise

prohibited

by

the

United

States

department

of

34

health

and

human

services.

35

-1-

LSB

5704YH

(1)

91

nls/ko

1/

1